IPAB Back In The Spotlight As Repeal Bill Clears House Subcommittee
This article was originally published in The Pink Sheet Daily
Executive Summary
House Energy and Commerce health panel votes to repeal IPAB; Ways and Means Committee plans a hearing in early March.
You may also be interested in...
CMS Budget Plan: $1 Bil. Increase For Administrative Activities Is New, But Drug Policy Proposals Are Old
CMS budget plan reprises Medicare drug rebates for dual eligibles, eliminating brand/generic patent settlements and other unsuccessful Rx proposals.
IPAB Members Will Be Named In Time To Begin Recommendations In 2014, Sebelius Says
The White House has begun discussions with potential board member nominees, HHS secretary tells House Energy and Commerce Health Subcommittee.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.